A liquid-phase blocking sandwich enzyme-linked immunosorbent assay (ELISA-3D) was developed to detect specific antibodies to the 3D protein in sera from foot-and-mouth disease (FMD) virus (FMDV)infected animals. The assay uses a nonstructural 3D recombinant protein and two polyclonal antisera, one for capture (bovine) and the other for detector (guinea pig). The specificity of the assay was demonstrated by negative results with 101 sera of cattle from the FMD-free zone in Argentina and with bovine and porcine sera raised against various RNA and DNA viruses. The ELISA-3D was able to detect antibodies in cattle after natural or experimental infection with FMDV of A, O, or C types as early as 5 days postinfection and at later stages in persistently infected animals. Comparison of the results with those obtained with the routinely used agar gel immunodiffussion test and a previously described ELISA, both employing a partially purified virus-infectionassociated antigen, shows that the ELISA-3D is highly sensitive and specific and gives reproducible results. Its use as a tool for monitoring viral activity and for certification of FMDV-free animals is recommended.
Foot-and-mouth disease (FMD) virus (FMDV), an aphtovirus of the family Picomaviridae, is the causal agent of a highly contagious and economically important disease of cloven-hooved animals. Differentiation between vaccinated and infected animals and detection of virus carriers are essential to evaluate the effectiveness of control and eradication campaigns.
A nonstructural antigen associated with FMDV replication, the virus-infection-associated (VIA) antigen, 5 is comprised mainly of the RNA polymerase, 11 designated as the 3D protein. The antigenicity of the protein is conserved among all serotypes. Antibody is induced by infection with the virus, but inactivated vaccine preparations produced from virus-infected cultures contain only low levels of VIA antigen. Antibody responses to VIA antigen after vaccination are therefore generally low and transient. 2, 13 Detection of anti-VIA antibody is used to discriminate between antibody elaborated by vaccination and by infection. The presence of circulating virus can be an indirect measure of the risk of a disease outbreak. 9 The most widely used procedure for measuring anti-body to VIA antigen is the agar gel immunodiffusion test (AGID 9 ). The method is simple to perform, but because of its low sensitivity, a liquid-phase blocking ELISA (ELISA-VIA) with higher sensitivity was developed. 3 Both of these methods were based on the use of partially purified antigen derived from infected cell cultures, which requires the handling of infectious virus in large volumes and is subject to variation in antigen quality among batches. The use of recombinant nonstructural proteins for diagnostic assays has been reported. An indirect ELISA using bacterially expressed VIA antigen was suggested for use in herd surveys of prevalence and incidence of disease. 18 However, the assay had low specificity. An indirect ELISA using bioengineered 3D protein had a 9% (27/300) reactivity with sera from an FMD-free area, suggesting that it was also of low specificity. 8 An enzyme-linked immunotransfer blot (EITB) assay capable of detecting specific antibody used a set of 5 recombinant DNAderived nonstructural viral proteins as probes, 1 of which was the 3D protein. 4 Although it had a high sensitivity and specificity, it is difficult to apply such a procedure to the testing of a large number of samples.
We developed a liquid-phase blocking sandwich ELISA (ELISA-3D) to detect specific antibody to the 3D protein in sera from FMDV-infected animals. In the present study, ELISA-3D was compared with ELISA-VIA. The results obtained here indicate that the ELISA-3D is a highly sensitive, specific, and reproducible method for monitoring viral activity in infected cattle and for certification of FMD-free areas.
Materials and methods
Recombinant 3D protein. The 3D protein was expressed as a fusion protein with glutathione-S-transferase (GST) using the pGEX expression system. 16 The source of the 3D gene was plasmid pT274, a an Escherichia coli pBR322 plasmid containing a 1,512-base-pair cDNA clone of the 3' end of the FMDV type A12 RNA genome. 14 Primers flanking the coding region for the 3D protein were synthesized to contain restriction endonuclease sites for BglII and EcoRI, enabling subcloning site of the pGEX-2T expression vector (digested with BamHI and EcoRI). 16 Expression of the GST-3D fusion protein was confirmed by sodium dodecyl sulfate polyacrylamide gel electrophoresis of protein extracts from plasmidtransformed E. coli cultures. A protein band of 80 kD corresponding to the combined molecular masses for GST and the FMDV RNA polymerase was observed. The specificity of the 80-kD expressed protein was confirmed by immunoblotting with monoclonal antibody specific to FMDV 3D protein.
The GST-3D fusion protein was purified from E. coli cultures by binding to and elution from glutathione sepharose using the methods previously described. 16 The fusion protein was soluble and recovered at high yield, 1-2 µg/ml of culture.
Control antigen, GST, was similarly purified from E. coli cultures transformed with the pGEX-2T plasmid.
ELISA-3D. The procedure was a liquid-phase blocking sandwich ELISA, essentially as previously described. 3 Test sera and known positive and negative sera were allowed to react with the GST-3D antigen and with the GST antigen and then added to microtitre plates previously coated overnight at 4 C with IgG from type C FMDV-infected convalescent cattle (capture serum). Detection of the unreacted GST-3D antigen was performed by addition of a guinea pig anti-type O FMDV serum (detector serum) and by an antiguinea pig IgG peroxidase conjugate. b Orthophenylenediamine c and 3% H 2 O 2 were used as chromogen and substrate, respectively. The plate was incubated for 15 min at room temperature, and the reaction was stopped by acidification with 2.25 M H 2 SO 4 . Optical densities (OD) were read with a microplate reader d at 492 nm. A positive reaction was that in which the OD was reduced more than 50% in comparison with that of controls without serum. Antibody titers were expressed as the final dilution of serum giving 50% of the mean OD value recorded in controls, where serum was absent.
VIA antigen. Partially purified VIA antigen was produced at the National Service of Animal Health (SENASA) as previously described. 3 Suspensions of C Argentina 85 FMDV strain propagated in suspension cultures of bovine tongue epithelium were inactivated with binary ethylenimine (BEI). VIA antigen was removed with 0.05% (w/v) DEAE-Sephadex A 50, e eluted by the addition of 1 M NaCl and 0.02 M Tris buffer (pH 7.6), and precipitated with ammonium sulfate.
ELISA-VIA. The followed procedure was as previously described 3 and was basically the same as described for the ELISA-3D, using partially purified VIA as antigen instead of 3D protein.
AGID. This test was conducted as previously described. g Test serum samples and positive control sera were placed peripherically in a 7-well pattern cut in 1% agar. The VIA antigen was added to the center well. Plates were incubated at room temperature and read after 72 hr.
Serum samples. Serum samples from cattle from the FMDfree area of Argentina (south of 42°S, Patagonia region), that were free of antibodies to type O, A, and C of FMDV as measured by liquid phase blocking sandwich ELISA 7 (LPBE) were used to establish specificity of the test. To evaluate nonspecific reactions with antibodies to several RNA and DNA viruses, reference sera with high antibody titers against vesicular stomatitis virus (VSV), bluetongue virus (BTV), bovine viral diarrhea virus (BVDV), porcine enterovirus (PEV), porcine herpesvirus type 1 (PHV-1), bovine herpesvirus type 1 (BHV-1), bovine herpesvirus type 4 (BHV-4), bovine herpesvirus type 2 (BHV-2), and African swine fever (ASF) were also tested.
Sera collected 5-565 days postinfection (dpi) from cattle and sheep experimentally infected with FMDV, and serum from naturally infected cattle were used. Serum samples taken from cattle after vaccination and revaccination with two commercial quadrivalent inactivated oil adjuvant vaccines (types O1 Caseros, A Argentina 79, A Argentina 87, and C Argentina 85) were also included.
Results
Standardization of reagents. The optimal concentrations of capture, detector, and conjugate sera were determined by checkerboard titration. Each reagent was used at the last dilution giving the maximum absorbance. The 3D antigen was used at a dilution to give 60% of the maximum absorbance obtained in the assay. ODs obtained with positive or negative sera when GST was used as antigen were comparable to those obtained with controls without antigen. The distribution of ODs for negative sera was obtained by examination of 40 serum samples, and the positive/ negative cutoff was established as a 50% reduction in OD at 1/5 dilution of serum (final dilution 1/10). All 101 negative cattle sera gave negative results by ELISA-3D at 1/10 dilution (log 10 = 1).
Ninety percent of naive cattle sera showed titrse below log,, = 0.3. No negative serum recorded an ELISA titer greater than log,, = 0.52. No reactivity was observed when reference sera with high antibody titers to heterologous bovine and porcine RNA and DNA viruses (VSV, BTV, BVDV, PEV, PHV-1, BHV-1, BHV-4, BHV-2, ASF) were examined by ELISA-3D. One hundred one of 111 cattle sera infected with O, A, or C FMDV types were positive by the ELISA-3D. Thus, the sensitivity was 90.9% (confidence interval = 96.2-85.54%). The test failed to detect antibodies in 10 of 111 postinfection sera that were also negative by AGID. Six of these sera were collected before 8 dpi, and 4/10 sera were collected after 533 dpi. ELISA-3D results were compared with those obtained by ELISA-VIA and AGID (Table 1) .
To assess the relative sensitivity of the assay, sera from 4 convalescent cattle were titrated by the ELISA-3D and AGID. The titers obtained with the ELISA-3D were 10-fold higher than those of the AGID.
The variability of the ELISA-3D between and within assays was also studied. The between-assay variation was determined by testing a positive serum serially diluted on 5 independent assays. The coefficient of variation (CV) obtained was 2.4%. To evaluate the variability within assays, 20 repetitions of a positive serum titration were performed in 2 plates. The mean CV was 2.75% (range, 2.5-3.0%).
Persistence of 30 antibodies during acute and convalescent state. The antibody response to 3D was studied in 4 cattle (nos. 4, 16, 18, 19) following experimental infection by contact with 2 calves infected with FMDV type O. Animal no. 4 had been vaccinated 8 months before the infection and had an antibody titer to O FMDV type by LPBE compatible with protection. 7 The other three (nos. 16, 18, 19) had never received vaccine and were free of antibodies to FMDV types O, A, and C on the day of infection. Serum samples were obtained serially between 0 and 233 dpi. Only the 3 cattle free of antibodies to FMDV showed clinical signs of disease.
During the persistent infection period (after 30 dpi), FMDV and viral RNA were detected from esophagealpharyngeal fluid up to 90 dpi in animal nos. 16 and 19, whereas only viral RNA was detected in animal nos. 4 and 18 up to 62 dpi.
Specific antibodies to the 3D protein were detected in animal no. 4 from 5 dpi. Further samples became positive in all cattle until the last sampling at 233 dpi by the ELISA-3D. Maximum titers of 3D antibodies were reached between 20 and 34 dpi (log,, 2.2-> 3.1), subsequently the antibody response decreased gradually in all cattle up to log,, < 1-1.16 at 233 dpi (Fig.  1B) . Higher antibody titers were detected in cattle that had shown clinical signs. However, all cattle showed similar 3D antibody titers at 233 dpi.
The 3D antibody results were compared with those obtained by AGID and the ELISA-VIA (Fig. 1A) . Similar results were obtained by both ELISA, but the AGID failed to identify infected animals at early stages of infection (0/4 at 5 dpi) and at extended times after recovery (1/4 at 233 dpi).
Detection of 3D antibodies in sera from infected cattle at later stages of persistent infection. Four cattle vac-
cinated with different dilutions of a FMDV O1 Caseros monovalent oil vaccine 30 days before exposure and 3 naive cattle were challenged by the intradermolingual route with 10 4 bovine infectious doses 50% (BID 50%) of the homologous strain. All cattle were negative for 3D and VIA antibodies by AGID before the exposure. The animals showed clinical symptoms and became persistently infected by FMDV (A. Sadir, unpublished data). All sera gave positive results until 470 dpi, 5 of 7 sera were positive up to 535 dpi, and 3 of 7 sera were positive until 565 dpi ( Fig. 2A) . Low 3D antibody levels (log 10 = 1.22-1.59) were reached after 470 dpi in all cattle (Fig. 2B) . No association was found between previous vaccination and persistence of 3D antibodies. In vaccinated and exposed cattle, 3D antibodies were detected up to 565 dpi, whereas in naive cattle exposed to FMDV, the antibodies to 3D persisted for 470-565 dpi.
Antibody response to 3D protein in vaccinated and revaccinated cattle. To examine the antibody response to 3D and VIA antigen after vaccination, sera from cattle vaccinated with 2 oil adjuvanted formulations used in the FMD control program were used. Both batches (vaccines A and B) protected more than 93% of the cattle in the official vaccine potency test and showed high titers of antibodies to O, A, and C types as measured by LPBE 7 prior to challenge. Five of 6 cattle immunized with FMD vaccine A became FMDV positive at 30 days postvaccination (dpv) by ELISA-3D. At 60 dpv, only 2 sera remained positive, and at 120 dpv, none of the vaccinated cattle had antibodies detectable by the ELISA-3D. The animals were revaccinated at 210 days after the first vaccination. A positive reaction was detected by ELISA-3D in 6/6 and in 2/6 cattle at 23 and 83 days post revaccination (dprv), respectively. Additional serum samples gave negative results. Low antibody titers (range, log 10 < 1-1.22) were also observed in positive serum samples by ELISA-3D at 60 dpv and 83 dprv. Negative results were obtained in 5 nonvaccinated cattle used as sentinels for FMDV circulation and that were housed with the vac-VIA antibodies after 60 dpv. Fourteen cattle vaccicinated calves. nated with vaccine B were examined at 60 dpv. No Figure 3 shows a comparison between results of 3D antibody response after vaccination was detected ELISA-3D and AGID. AGID was not able to detect in the sera of the animals vaccinated with this vaccine.
Discussion
Precise evaluation of FMD status in regions with a vaccination program is necessary to monitor the progress of a control campaign. Serologic assays that detect antibody to nonstructural proteins have shown specificity in assessing the postinfection state 3, 4, 8, 9 and offer various advantages for use in epidemiologic surveys and in serology for certification of FMD free animals. 15 The ELISA-3D reported here uses a nonstructural 3D recombinant protein in LPBE and two polyclonal antisera, one as capture (bovine) and the other as detector (guinea pig). It is based on the ability of the antibodies anti-3D contained in the test serum to block the trapping of 3D antigen by the capture antibody.
The cutoff value of log 10 = 1 assured good differentiation between reactors and nonreactors. Negative serum titers were distributed with an average of log 10 = 0.31, and no serum with a titer higher than log 10 = 0.52 was recorded. Furthermore, postinfection sera showed minimum titers of log 10 = 1.1.
The specificity of the assay was demonstrated by negative results in 101 negative sera from cattle from the FMD-free zone and in sera raised against various RNA and DNA viruses. The sensitivity of the 3D-ELISA was comparable to that obtained with ELISA-VIA 3 and lo-fold greater than the AGID. It was able to detect antibodies in cattle after natural or experi-mental infection with FMDV A, O, or C types as early as 5 dpi and at later stages (565 dpi) in persistently infected animals, when AGID gave negative results. The test failed to detect antibodies in 10 of 111 postinfection sera that were negative by AGID. Six of these sera were collected shortly after infection, where no or low antibody production may occur. In addition, negative results in 4/10 sera collected after 533 dpi may be due to absence or low level of antibody, lower than the assay sensitivity. Negative results or low antibody level were also found in these sera when antibodies to structural proteins were measured by LPBE using the FMDV type homologous to the strain used in the experimental infection as antigen.
Broad variation in the VIA antibody response of individual animals after infection has been reported. 1, 6 Most of the infected cattle developed VIA antibodies detected by AGID at least during 6 months after the infection. Positive results were found frequently after one year post-infection and occasionally after 2 years postinfection. Findings of these experiments agree with those in prior reports 4,10 in which antibodies to nonstructural proteins, including 3D have been detected by EITB both at early and late phases of infection. The induction of VIA antibodies by vaccination has been reported. 1.13 VIA antigen was demonstrated in the supernatant of vaccine cultures and was inactivated with AEI 13 . Recently, evidence that RNA polymerase is a component of at least 20-30% of the virus particles was obtained.
12 This evidence is difficult to reconcile with previous reports of herds under vaccination programs in which VIA antibodies rates declined according to the intensity of the campaign. 17 The 3D antibody response in vaccinated cattle varied according to the immunogen applied. Despite similarities in the vaccine protection test, a transient immune response was induced by vaccine A, whereas no 3D antibody was yielded using vaccine B. These differences may be due to differences in antigen preparation between the vaccines; these differences could not be ascribed to poor quality of vaccines employed. Vaccines A and B are produced by different manufacturers and both batches performed in potency tests with more than 93% of cattle protected, and serology at 60 and 90 days revealed high antibody titers to structural proteins to all FMDV strains contained in the vaccine.
Antibodies to nonstructural proteins, including 3D, were not detected by EITB assay in sera from cattle vaccinated with BEI-inactivated aluminum gel or oil adjuvant vaccine. 4 However, antibodies to 3D protein were obtained after vaccination with highly concentrated antigen or without proper clarification. 4 The 3D antibodies were detected after vaccination, and immune response lasted for 60 days after vaccination and 90 days after revaccination. Sampling for epidemiologic studies are carried out 4-6 months after the last vaccination in cattle under 2 years of age. According to results obtained in this study, it would be possible to take samples from young cattle under field conditions in which 3D antibodies induced by vaccination were not present.
The ELISA-3D can be used to monitor viral activity in large cattle populations and for certification of FMDV-free animals for import and/or export testing. This assay is rapid and relatively simple to perform. In addition, the use of a bioengineered antigen has advantages for practical application, such as safety (it does not require manipulation of infective virus) and provide a consistent source of antigen.
